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The present study examined the eﬀects of squid phosphatidylserine (Squid-PS) on the learning and memory function and the
neural activity in rats with TMT-induced memory deﬁcits. The rats were administered saline or squid derived Squid-PS (Squid-
PS 50mgkg−1, p.o.) daily for 21 days. The cognitive improving eﬃcacy of Squid-PS on the amnesic rats, which was induced by
TMT, was investigated by assessing the passive avoidance task and by performing choline acetyltransferase (ChAT) and acetyl-
cholinesterase (AchE) immunohistochemistry. 18F-Fluorodeoxyglucose and performed a positron emission tomography (PET)
scan was also performed. In the passive avoidance test, the control group which were injected with TMT showed a markedly lower
latency time than the non-treated normal group (P<0.05). However, treatment of Squid-PS signiﬁcantly recovered the impair-
ment of memory compared to the control group (P<0.05). Consistent with the behavioral data, Squid-PS signiﬁcantly alleviated
the loss of ChAT immunoreactive neurons in the hippocampal CA3 compared to that of the control group (P<0.01). Also, Squid-
PS signiﬁcantly increased the AchE positive neurons in the hippocampal CA1 and CA3. In the PET analysis, Squid-PS treatment
increased the glucose uptake more than twofold in the frontal lobe and the hippocampus (P<0.05, resp.). These results suggest
that Squid-PS may be useful for improving the cognitive function via regulation of cholinergic enzyme activity and neural activity.
1.Introduction
Trimethyltin (TMT) is an organotin compound with potent
neurotoxicant eﬀects. This substance is regarded as being
particularly useful for studying the response to injury on
account of the distinct pattern of degeneration it causes in
rodent brain. In particular, the rat hippocampus constitutes
the most suitable model for TMT-induced brain injury [1–
4]. The molecular basis for the selective vulnerability of spe-
ciﬁc neuronal populations to neuronal insults has been a
key focus in the ﬁelds of neurology and neuropathology
[5]. TMT-induced neurodegeneration is characterized by
massive neuronal death that is mainly localized in the
limbic system and especially in the hippocampus, and this
is accompanied by reactive gliosis, epilepsy, and marked
neurobehavioralalterations,andsothisisconsideredauseful
model of neurodegeneration and selective neuronal death
[5–11]. Also, in rats, TMT induces the degeneration of
pyramidalneuronsinthehippocampusandthecorticalareas
(pyriform cortex, entorhinal cortex, and subiculum) con-
nected to the hippocampus, but there is also neuronal loss
in the association areas [6, 12, 13]. Furthermore, behavioral
studies have shown increased locomotor activity, disruption
in self-grooming, and learning deﬁcits in TMT-intoxicated
rats[1,5,14–21].TMTintoxicationimpairstheperformance
of learning acquisition of water maze and Biel maze (water
avoidance) tasks as well as the performance of Hebb-
Williams maze and radial arm maze tasks. In addition, TMT2 Evidence-Based Complementary and Alternative Medicine
intoxication produces deﬁcits in passive avoidance retention,
but not in the acquisition of the passive avoidance response
[2–4, 10, 21, 22]. Furthermore, deﬁcits in the acquisition
of active avoidance at the beginning of training have been
reported [16]. Moreover, TMT has been shown to produce
eﬀects on operant behavior since TMT-intoxicated rats had
higher rates of lever pressing under a ﬁxed-ratio schedule of
food presentation [20], and TMT impaired the performance
ofdiﬀerentialreinforcementatlowresponseratesinanoper-
ant schedule [23]. These anatomical and behavioral ﬁnd-
ings have made TMT-intoxicated rats an attractive model for
degenerative diseases such as AD, which is the most common
cause of dementia [16].
Phosphatidylserine (PS), a phospholipid nutrient, is
active in cell membranes and is the major acidic phospho-
lipid component in the membranes of the brain. Membranes
are the working surfaces of every cell, carrying out the essen-
tial functions of cellular communication and hormonal sig-
nal transduction [24, 25]. Nerve cells, in particular, depend
on healthy membrane function for normal neurotrans-
mitter metabolism and nerve signal transmission [26]. Also,
PS assists in maintaining adequate glucose utilization in the
brain.Glucoseisthepreferredenergysubstratefornervecells
which, unlike other cells, are unable to use fatty acids or pro-
teins for energy production. Brain glucose utilization, an
indicator of brain activity, often declines during aging [27].
The present study was undertaken to evaluate the neu-
roprotective eﬀect of Squid-PS on the TMT-induced mem-
ory deﬁcit in rats and to elucidate the mechanism underlying
these protective eﬀects in rats. Rats were tested on a passive
avoidance test for learning and memory. The analyzed para-
meters included the expression of cholinergic neurons and
neural activity in the hippocampus.
2.MaterialsandMethods
2.1. Animals and the Experimental Design. Male Sprague-
Dawley rats weighting 250–280g (8 weeks old) each were
purchasedfromSamtacoAnimalCorp.(Kyungki-do,Korea).
The animals were housed in individual cages under light-
controlled conditions (12/12-hour light/dark cycle) and at
23◦Croomtemperature.Foodandwaterweremadeavailable
ad libitum. All the experiments were approved by the Kyung
Hee University institutional animal care and use committee.
Also, this experimental protocol was approved by an Instit-
utional Review Committee for the Use of Human or Animal
Subjects or that procedures are in compliance with at
least the Declaration of Helsinki for human subjects, the
National Institutes of Health Guide for Care and Use of
Laboratory Animals (Publication no. 85-23, revised 1985),
the UK Animals Scientiﬁc Procedures Act 1986, or the Euro-
pean Communities Council Directive of 24 November 1986
(86/609/EEC). The rats were allowed at least 1 week to adapt
to their environment before the experiments.
The rats were injected intraperitoneally (i.p.) with TMT
(8.0mg/kg, body weight) dissolved in 0.9% saline, and then
they were returned to their home cages.
The rats were randomly assigned to three groups of six
individuals each as follows: nontreated, na¨ ı v en o r m a lg r o u p
(normal); saline-treated group (control); 50mgkg−1 Squid-
PS-treated group (Squid-PS 50) used in this study, which
were manufactured and kindly provided by Doosan Co.
Glonet BU (Youngin, Korea). The rats were orally admin-
istrated with PS, daily for 21 days.
2.2. Passive Avoidance Task (PAT). A passive avoidance task
was performed after 21 days of the administration of Squid-
PS. Rats were trained in a step-through inhibitory avoidance
task. On the training trial, each rat was placed on a lighted
platform outside a hole leading to a dark compartment.
When the rat stepped into the dark compartment, a constant
current foot shock (5V, 0.5mA, 10 seconds) was delivered
twice. For the retention test, at 24 hours (day1), and at 2 and
3 days later, each rat was again placed on the platform, and
the latency to step through was recorded.
2.3. Immunohistochemistry. Brieﬂy, the rats were anes-
thetized (sodium pentobarbital, 100mg/kg, IP) and then
perfused transcardially with heparinized phosphate-buﬀer-
edsaline (PBS;pH 7.4) for30min followedby4%paraform-
aldehyde in 0.1M phosphate buﬀer (pH 7.4) for 10–15min.
The brains were postﬁxed in the same ﬁxative overnight, cry-
oprotected in 30% sucrose solution in PBS, embedded and
serially sectioned on a cryostat (Leica, Germany) at 30μm
thickness in the coronal plane, and were collected in PBS.
Theprimaryantibodiesagainstthefollowingspeciﬁcantigen
were used: cholinacetyl transferase (sheep polyclonal ChAT,
concentration 1:2000; Cambridge Research Biochemicals,
Cleveland, UK) and acetylcholinesterase (rabbit polyclonal
AchE, concentration 1:1000; Cambridge Research Biochem-
icals, Cleveland, UK). The primary antibody was prepared
and diluted in 0.3% PBST, 2% blocking serum, and 0.001%
kehole limpet hemocyanin (Sigma, USA). The sections were
incubated in the primary antiserum for 72h at 4◦C. Follow-
ing rinsing in PBST, sections were incubated for 2hr at room
temperature in biotinylated rabbit anti-sheep or antirabbit
serum (Vector Laboratories, Burlingame, CA, USA) diluted
200X in PBST containing 2% normal rabbit serum. Fol-
lowing a further rinsing in PBS, the tissue was developed
using diaminobenzidine (Sigma, USA) as the chromogen.
The images were captured using a DP2-BSW imaging system
(Olympus, CA, USA), and they were processed using Adobe
Photoshop. For measuring the cells that were positive for
ChAT and AchE, the grid was placed on CA1 and CA3 in the
hippocampus area according to the method of Paxinos et al.
[28]. The number of cells was counted at 100x magniﬁcation
using a microscope rectangle grid that measured 200 ×
200mm. The cells were counted in three sections per rat
within the hippocampal CA1 and CA3 areas. The brain sec-
tions were visually inspected at 3 diﬀerent anteroposterior
levels extending from −2.12 to −6.04mm [28].
2.4. [F-18]FDG Micro-PET Scan. All the rats were deprived
offoodfor12–15hbeforetheexperimentstoenhancethe[F-
18]FDGuptakeinthebrain[20].Eachanimalwasplacedon
a heating pad in a cage and warmed for at least 30min before
the [F-18] FDG injection. The temperature of the cages was
kept at 30◦C throughout the uptake period in accordanceEvidence-Based Complementary and Alternative Medicine 3
with an optimized [F-18] FDG uptake protocol [20]. [F-18]
FDG (500μCi/100g body weight) was injected through a tail
vein, and the rats were anesthetized with 2% isoﬂurane in
100% oxygen (Forane solution; ChoongWae Pharma). For
the PET imaging, a Siemens Inveon PET scanner (Siemens
Medical Solutions, USA) was used throughout the study.
T h et r a n s v e r s er e s o l u t i o nt h a tw a su s e dw a s<1.8mm at the
center [20, 29].
The transmission PET data was acquired for 15min
using a Co-57 point source with an energy window of
120∼125keV. One mCi of [F-18] FDG was injected. After
allowingfor30minoftraceruptaketime,30minofemission
PET data was acquired within an energy window of 350∼
650keV. The emission list-mode PET data was sorted into
3D sinograms and reconstructed using 3 DRP methods. The
pixel size of the reconstructed image was 0.15 × 0.15 ×
0.79mm3. Attenuation and scatter corrections were per-
formed for all the datasets. Automated regions of interest
(ROI) were used to sample cerebral metabolic rate for glu-
cose from the spatially normalized PET within speciﬁc AD-
related brain regions (hippocampus, prefrontal cortex).
2.5. Voxel-Based Statistical Analysis. Voxel-based statistical
analysis was performed to compare the cerebral glucose
metabolism of the Squid-PS and control datasets. The pro-
cedure used for SPM analysis of the animal PET data was
as previously described in our previous study [29]. Brieﬂy,
for eﬃcient spatial normalization, only the brain region was
extracted. A study-speciﬁc template was then constructed
using all the datasets. The PET data was spatially normalized
onto a rat brain template and smoothed using a 3mm Gaus-
sian kernel. Count normalization was performed. A voxel-
wised t-test between the Squid-PS and normal datasets was
performed using the Statistical Parametric Mapping 5 pro-
gram (P<0.05, K>50).
2.6. Statistical Analysis. Statistical comparisons were done
for the behavioral and histochemical studies using one-way
o rt w o - w a yA N O V Aa n dr e p e a t e dm e a s u r e so fA N O V A ,r e s -
pectively,andTukey’s posthoc testwasdone.Alloftheresults
are presented as means ± SEM, and SPSS 15.0 for Windows
was used for analysis of the statistics. The signiﬁcance level
was set at P<0.05.
3. Results
3.1.Eﬀectof Squid-PSonthePerformanceofthePassive Avoid-
ance Task. As shown in Figure 1, the control group showed
a memory deﬁcit in the passive avoidance test compared to
the normal group (F2,11 = 2.68, P<0.05). However, the
Squid-PS group showed improved memory compared to the
control (Day 3, P<0.01).
3.2. ChAT Immunoreactive Neurons of the Hippocampus.
ChAT immunoreactive cells in the diﬀerent hippocampal
subregions are shown in Figure 2. Post-hoc comparisons
indicated that the ChAT immunoreactivity in the hippocam-
pal CA1 and CA3 of the control group was signiﬁcantly
reducedcomparedwiththatofthenormalgroup(F2,16 =5.4,
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Figure 1: The eﬀect of Squid-PS on passive avoidance task. Data
represent means ± SEM of the latency in the passive avoidance task,
on learning and memory performance. Rats were exposed to the
acquisition trial (DAY1), and retention tests were performed on the
following two days (DAY2-3). Statistics: one-way ANOVA test, fol-
lowed by LSD test. ∗P<0.05 as compared with the correspond-
ing data of normal group. ++P<0.01 as compared with the cor-
responding data of control group.
P<0.05;F2,16 =15.6,P<0.001).Also,ChATreactivityinthe
Squid-PS group was higher than that of the control group,
and particularly in CA3 (P<0.01).
3.3. AchE Immunoreactive Neurons of the Hippocampus.
AchE immunoreactive cells in the diﬀerent hippocampal
subregions are shown in Figure 3.P o s th o cc o m p a r i s o n s
indicated that the AchE activity in the hippocampus of the
control group was signiﬁcantly lower than that of the normal
group (P<0.01). In particular, there were signiﬁcant diﬀer-
ences in both CA1 (F2,13 = 7.3, P<0.01) and CA3 (F2,13 =
7.6, P<0.01). However, the AchE reactivity in the Squid-
PS group was higher than that of the control group, and
particularly in CA1 (P<0.01) and CA3 (P<0.05).
3.4. Change in Brain Glucose Metabolism. The analysis of the
brain glucose metabolism analysis was shown in Figure 4,
and Table 1. The result of voxel-wised shows comparison
between the Squid-PS and control datasets. FDG-PET image
scans indicated diﬀerences in the cerebral metabolic rate
of glucose from the hippocampus to prefrontal cortices
between the control and Squid-PS group. On the SPM ana-
lysis, the glucose metabolism of the Squid-PS datasets was
signiﬁcantly increased in the hippocampus and frontal lobe
compared to that of the control (P<0.05).
4. Discussion
The present study demonstrated that TMT injections pro-
duced severe deﬁcits in the rats’ performances in a passive4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: (a) The photograph of ChAT immunoreactivity on hippocampus. (b, e) normal group, (c, f) control group, and (d, g) Squid-PS
group ChAT expression on the hippocampus. Each column represents the mean value ± SEM per group. Statistics: one-way ANOVA test,
followed by LSD test. ∗∗P<0.01, ∗∗∗P<0.001 as compared with the corresponding data of normal group. ++P<0.01 as compared with
the corresponding data of control group.
avoidance task along with signs of neurodegeneration,
including decreased cholinergic neurons and neural glucose
activityinthehippocampus.RepeatedtreatmentwithSquid-
PS attenuated the TMT-induced learning and memory
deﬁcits in the passive avoidance task, and it had a protective
eﬀect against the TMT-induced decrease in cholinergic pos-
itive neurons. Also, Squid-PS increased the glucose uptake
approximately twofold in the frontal lobe and hippocampus.
Intoxication with trimethyltin (TMT) leads to profound
behavioral and cognitive deﬁcits in both humans [30]a n d
experimental animals [7, 10]. TMT is known to be widely
used as plastic stabilizers, wood preservatives, anti-corrosion
coatings, pesticides, and kill snails, as well as applied by
chemicaldisinfectorandsterilization.Soitisclinicallymean-
i n g f u lt h a th u m a n sa sw e l la sa n i m a l sc a nb ee x p o s e dt o
it in living environment. In rats, TMT induced the degen-
eration of the pyramidal neurons in the hippocampus and
the cortical areas (pyriform cortex, entorhinal cortex, and
subiculum) connected to the hippocampus, but there was
also neuronal loss in the association areas [6, 11, 12, 14, 15].
Furthermore, behavioral studies have shown increased dis-
ruption of the memory, and learning deﬁcits of TMT-into-
xicated rats [20]. TMT intoxication impairs the acqui-
sition of water maze performance [31]. The memoryEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: (a) The photograph of AchE immunoreactivity on hippocampus. (b, e) normal group, (c, f) control group, and (d, g) Squid-PS
group AchE expression on the hippocampus. Each column represents the mean value ± SEM per group. Statistics: one-way ANOVA test,
followed by LSD test. ∗P<0.05, ∗∗P<0.01 as compared with the corresponding data of normal group. +P<0.05, ++P<0.01 as compared
with the corresponding data of control group.
impairment produced by TMT in the current study is consis-
tent with the previous reports of learning impairments [14,
31–33].Duringthetrainingtrialinastep-throughinhibitory
avoidance task after shock, there were no diﬀerences among
thegroups.TreatmentofSquid-PSseemstobemoreeﬀective
in reversing the memory impairment of late phase, rather
than early phase, suggesting that it may facilitate process of
memory consolidation. It has been previously reported that
PS has profound curative eﬀects on improving the memory
and cognitive function of an Alzheimer’s disease-like animal
model [22, 34]. Zanotti et al. also showed that the treatment
of PS in a scopolamine-induced animal model enhanced the
learning and memory abilities of the rats [34]. But there was
no study using Squid-PS in TMT intoxication model yet.
Table 1: It shows the results of voxelwise comparison between
Squid-PSandcontroldatasets.InSPManalysis,thecerebralglucose
metabolism of Squid-PS datasets was increased signiﬁcantly in the
hippocampus and frontal lobe compared to control.
Brain area Coordinates (x, y, z) Z value
Frontal lobe (−2.4, 2.7, 8.1) 2.14
Hippocampus (Right) (7.5, 2.1, 2.4) 2.85
Hippocampus (Left) (−6.5, 2.1, 2.5) 2.13
The eﬀects of Squid-PS on the central acetylcholine sys-
tem were also examined by performing immunohistochem-
istry of the hippocampal neurons. The degeneration of6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Brain regions where regional FDG uptakes in Squid-PS were signiﬁcantly higher than in control (hippocampus and frontal lobe).
the cholinergic innervation from the basal forebrain to the
hippocampal formation in the temporal lobe is thought to
be one of the factors determining the progression of memory
decay,bothduringnormalagingandAD[35].Thebestavail-
able marker for cholinergic neurons in the basal forebrain is
ChAT activity. ChAT synthesizes the neurotransmitter acety-
lcholine in the basal forebrain, cortex, hippocampus, and
amygdala. A signiﬁcant reduction in ChAT activity in the
postmortem brains of demented patients has been reported.
In addition, there was a 20–50% decrease in ChAT activity
in the hippocampus of the TMT-induced rats in this current
study.However,thepresentresultsshowthatSquid-PSexerts
beneﬁcial eﬀects on cholinergic neurotransmission in the
brain by increasing the hippocampus ChAT activities. Also,
acetylcholine esterase (AchE) is an enzyme which breaks
down acetylcholine and is a well-known target and bio-
marker for memory dysfunction or dementia [20]. In AchE
histochemistry, the Squid-PS group showed higher AchE
reactivity in both hippocampal CA1 and CA3. These results
are consistent with previous reports showing that the cho-
linergic neurons in the brain are involved in learning and
memory in humans and animals [36, 37]. In particular, the
hippocampal cholinergic neurons are involved in the forma-
tion and maintenance of short-term working memory or
retention and retrieval processes in long-term reference
memory [16, 18, 38–41]. Based on a previous study, this
result suggests that the Squid-PS treatment can promote the
memory function.
The name “PET” comes from Positron Emission Tomog-
raphy. It is a new scanning technique in medical research.
Small animal PET experiments can be performed using a
variety of dedicated small animal scanners (ATLAS, RatPET,
microPET). It is a functional imaging modality at molecular
levelandprovidesvaluableinsightsintobiochemical,physio-
logical, pathological or pharmacological process in vivo.
Recent research eﬀorts ﬁnd its application in a wide area,
ranging from basic insights into the normal physiology
and disease processes to drug and radiotracer development
and gene therapy. The present study showed that the PET
analysis, the cerebral glucose metabolism of the Squid-PS
datasets was signiﬁcantly increased in the hippocampus and
frontal lobe as compared to the control. An obvious limita-
tion of our study is that the spatial resolution of the present
micro-PET system is not high enough to permit more
speciﬁc analysis of the activity changes within certain brain
structures. Nevertheless, there have been several studies that
have investigated the brain activity changes in small animals
using micro-PET technology [2, 20]. Thus, an important
point of our study is that in spite of the limited spatial resol-
ution of the micro-PET system, we were able to detect the
TMT-induced focal brain changes.
In summary, treatment with Squid-PS attenuated the
TMT-induced learning and memory deﬁcits in the passive
avoidance test, and Squid-PS treatment had a protective
eﬀect against a TMTinduced decrease of the cholinergic neu-
rons and neural activation. Thus, Squid-PS is a good candi-
date of neuroprotective agent for treatment of Alzheimer’s
disease. Further studies that will examine the eﬀects of
Squid-PS activation on additional behavioral test will help to
elucidatewhetherincreasingthecentralcholinergicsignaling
may also improve other types of memory.
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